Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: Cyclic citrullinated peptide;Vroegdiagnostiek van reumatoïde artritis met een test op basis van een specifiek antigeen: Cyclisch gecitrullineerd peptide

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 5, 2003, Pages 191-194

  Van Venrooij, W J ^a   Van De Putte, L B A ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIBODY; FIBRIN; PEPTIDE; RHEUMATOID FACTOR;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; INFLAMMATION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; TITRIMETRY; TREATMENT PLANNING;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CITRULLINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 0037319655     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
2. Sutton B, Corper A, Bonagura V, Taussig M. The structure and origin of rheumatoid factors. Immunol Today 2000;21:177-83.
3. Boekel MAM van, Vossenaar ER, Hoogen FHJ van den, Venrooij WJ van. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4:87-93.
4. Nienhuis RLF, Mandema EA. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann Rheum Dis 1964;23:302-5.
5. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
6. Schellekens GA, Jong BAW de, Hoogen FHJ van den, Putte LBA van de, Venrooij WJ van. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
7. Reparon-Schuijt CC, Esch WJE van, Kooten C van, Schellekens GA, Jong BAW de, Verooij WJ van, et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001:44:41-7.
8. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166: 4177-84.
9. Putte LBA van de, Noordhoek Hegt V, Overbeek TE. Activators and inhibitors of fibrinolysis in rheumatoid and nonrheumatoid synovial membranes. A histochemical study. Arthritis Rheum 1977;20: 671-8.
10. Schellekens GA, Visser H, Jong BAW de, Hoogen FH van den, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
11. Jaarsveld CHM van, Borg EJ ter, Jacobs JWG, Schellekens GA, Gmelig-Meyling FHJ, Booma-Frankfort C van, et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999;17:689-97.
12. Kroot EJJA, Jong BAW de, Leeuwen MA van, Swinkels H, Hoogen FHJ van den, Hof M van 't, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
13. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65.
14. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.
15. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-93.
16. 33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001;60:67-8.
17. Palosuo T, Tilvis R, Strandberg T, Aho K. Filaggrin-related antibodies among the aged. Ann Rheum Dis [ter perse].
18. Venrooij WJ van, Boekel MAM van, Hoogen FHJ van den, Drijfhout JW. De 2e generatie anti-CCP-test voor de vroege detectie van reumatoïde artritis. Ned Tijdschr Reumatol 2002;2:6-10.
19. Jansen AL, Horst-Bruinsma I van der, Schaardenburg D van, Stadt RJ van de, Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074-6.
20. Rantapää-Dahlqvist S, Jong BAW de, Hallmans G, Wadell G, Sundin U, Venrooij WJ van. Antibodies against citrullinated peptides (CCP) predict the development of rheumatoid arthritis [abstract 453]. Arthritis Rheum 2002;46:S200.
21. Nielen MMJ, Schaardenburg D van, Stadt R van de, Horst-Bruinsma IE van der, Koning MHM de, Habibuw M, et al. Autoantibodies in serum of blood donors precede symptoms of rheumatoid arthritis by 1 to 6 years [abstract 955]. Arthritis Rheum 2002:46:S370.
22. Venrooij WJ van, Hazes JM, Visser H. Anticitrullinated protein/-peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002;60:383-8.